Clinical trial
The Combination of Letrozole (LE) and Clomiphene Citrate (CC) or LE Alone for Ovulation Induction in Women With WHO Group II/IV Ovulatory Disorders: A Randomized Controlled Trial
NCT06934785 is registered in ClinicalTrials.gov with Mỹ Đức Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- The Combination of Letrozole (LE) and Clomiphene Citrate (CC) or LE Alone for Ovulation Induction in Women With WHO Group II/IV Ovulatory Disorders: A Randomized Controlled Trial
- Lead sponsor
- Mỹ Đức Hospital
- Phase
- Not applicable
- Overall status
- Recruiting
- Start date
- April 28, 2025
- Completion date
- June 30, 2027
- Enrollment
- 600 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
clomiphene citrate, letrozole, ovulation disorder, ovulation induction